BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Chlamydia Infection Diagnostics and Therapeutics Market: Advancements in Chlamydia Screening to Create Lucrative Opportunities

  The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities, especially in developing economies across regions such as Asia Pacific and Latin America.

  January 6, 2021

   · 

  5 min read
• Myeloproliferative Disorders Drugs Market demand has been expanding on account of key advancements in the domain of oncology treatments

  Myeloproliferative disorders are a group of blood cancers characterized by the abrupt growth of abnormal white blood cells, platelets, or red blood cells.

  January 6, 2021

   · 

  3 min read
• Vacuum Mixing Devices Market | Latest Trends and Revenue Analysis Report

  It is of utmost importance for bone cement to have minimum porosity and maximum fatigue strength.

  January 6, 2021

   · 

  3 min read
• Superficial Radiation Therapy System Market | Artificial Intelligence to Drive More Opportunities

  In 1890 Wilhelm Conrad Roentgen, a German physics professor, presented his lecture titled “Concerning a New Kind of Ray” and introduced X-ray and its application to vast domain of healthcare.

  January 6, 2021

   · 

  4 min read
• RNA Analysis/Transcriptomics Market | Competitive and Fragmented Landscape to Help in Market Development

  The RNA analysis/transcriptomics market may pick up colossal development across the appraisal time of 2019-2029 on the back of the raising progressions across the transcriptomics area.

  January 6, 2021

   · 

  2 min read
• Business

  Eleva Secures up to EUR 60 million to Advance a Drug Candidate, Appoints New Board Member

  Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn.

  January 6, 2021

   · 

  1 min read
• Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen™ in China

  Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharm, has a leading liver drug franchise with a major presence in liver disease hospitals in China

  January 6, 2021

   · 

  9 min read
• Deals

  Autolus Therapeutics provides business outlook for 2021 & 2022

  Company prioritizes AUTO1, a potentially transformational treatment for Adult Acute Lymphoblastic Leukemia (ALL), with full data from the AUTO1-AL1 study expected in 2022

  January 6, 2021

   · 

  7 min read
• OBI Pharma, Inc. to Present at the 39th J.P. Morgan Healthcare Conference

  OBI Pharma, Inc., a Taiwan biopharma company, announced that Tillman Pearce, MD., Chief Medical Officer, will present a company and clinical development overview at the 39th Annual J.P. Morgan Digital Healthcare Conference on Monday, January 11, 2021 at 11:00 a.m. EST/ 8:00 a.m. PST.

  January 6, 2021

   · 

  1 min read
• Deals

  Sartorius to acquire Novasep’s chromatography process equipment division

  The life science company Sartorius announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.

  January 6, 2021

   · 

  4 min read